Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dose 131I-mIBG as consolidation therapy in pediatric patients with relapsed neuroblastoma and ganglioneuroblastoma: the Japanese experience.
Wakabayashi H, Kayano D, Inaki A, Araki R, Kuroda R, Ikawa Y, Fujiki T, Akatani N, Yamase T, Watanabe S, Hiromasa T, Kunita Y, Mori H, Saito S, Nishimura R, Wada T, Kinuya S. Wakabayashi H, et al. Among authors: kuroda r. Ann Nucl Med. 2020 Nov;34(11):840-846. doi: 10.1007/s12149-020-01514-2. Epub 2020 Aug 29. Ann Nucl Med. 2020. PMID: 32862362
Diagnostic Use of Post-therapy 131I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma.
Wakabayashi H, Kayano D, Inaki A, Araki R, Kuroda R, Akatani N, Yamase T, Watanabe S, Hiromasa T, Kunita Y, Mori H, Saito S, Ikawa Y, Fujiki T, Kinuya S. Wakabayashi H, et al. Among authors: kuroda r. Diagnostics (Basel). 2020 Sep 2;10(9):663. doi: 10.3390/diagnostics10090663. Diagnostics (Basel). 2020. PMID: 32887257 Free PMC article.
Phase I/II clinical trial of high-dose [131I] meta-iodobenzylguanidine therapy for high-risk neuroblastoma preceding single myeloablative chemotherapy and haematopoietic stem cell transplantation.
Kuroda R, Wakabayashi H, Araki R, Inaki A, Nishimura R, Ikawa Y, Yoshimura K, Murayama T, Imai Y, Funasaka T, Wada T, Kinuya S. Kuroda R, et al. Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1574-1583. doi: 10.1007/s00259-021-05630-7. Epub 2021 Nov 27. Eur J Nucl Med Mol Imaging. 2022. PMID: 34837510 Clinical Trial.
1,211 results